Search for: "Bayer Laboratories, Inc."
Results 81 - 100
of 161
Sorted by Relevance
|
Sort by Date
6 Jun 2012, 1:24 pm
Bayer Pharmaceuticals was formerly known as Berlex, Inc. which was formerly known as Berlex Laboratories. [read post]
3 Jul 2012, 4:26 am
Bayer Pharmaceuticals was formerly known as Berlex, Inc. which was formerly known as Berlex Laboratories. [read post]
5 Jul 2013, 5:00 am
Wyeth Laboratories Inc., 734 A.2d 1245, 1259 (N.J. 1999). [read post]
20 Mar 2009, 2:05 am
Cutter Laboratories, Inc., 137 Cal. [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an… [read post]
13 Aug 2012, 7:02 pm
Drugs that are SSRIs: • Zoloft, which is made by Pfizer • Paxil, by GlaxoSmithKilne • Celexa, by Forest Laboratories • Effexor by Wyeth Pharmaceuticals • Pristiq, also by Wyeth • Prozac, which is made by Eli Lilly • Lexapro, by Forest Laboratories • Luvox, by Jazz Pharmaceuticals • Symbyax, by Eli Lilly Studies, such as those appearing in the New England Journal of Medicine and Obstetrics and Gynecology, support these families… [read post]
16 Aug 2022, 8:00 am
Abbott Laboratories, Inc. and AbbVie, Inc., 2022 IL App (1st) 210478 (June 23, 2022). [read post]
4 Aug 2010, 12:21 am
Roxane Laboratories Inc. [read post]
23 Dec 2009, 12:40 am
Bayer Bioscience N.V. [read post]
12 Jun 2009, 10:49 am
Opinion below (Federal Circuit) Petition for certiorari Brief in opposition of respondents Barr Laboratories, Inc. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
25 Jan 2010, 5:00 am
See Basic, Inc. v. [read post]
22 Dec 2010, 3:01 am
Watson Laboratories, Inc. [read post]
31 Dec 2009, 7:25 am
Court of Appeals in New York City, considering an action challenging a settlement agreement between drug maker Bayer AG and the generic defendant Barr Laboratories, Inc. [read post]
13 May 2010, 4:58 pm
Barr Laboratories, Inc. [read post]
11 Nov 2010, 12:54 pm
Syntex Laboratories, Inc., 444 So.2d 203, 205-06 (La. [read post]
8 Dec 2010, 2:20 am
Highlights this week included: India: Supreme Court dismisses Bayer’ petition in patent linkage matter (Generic Pharmaceuticals and IP) (Spicy IP) (GenericsWeb) (SiNApSE) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
22 Jun 2011, 4:09 am
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods: Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US: Manager’s Amendment (and… [read post]
9 Nov 2015, 4:00 am
The court also considered a ‘terminal disclaimer’ filed by a patentee in Bayer Inc. v. [read post]
